Espina, Nestor B.
HRN: 18-68-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/15/2024
05/22/2024
IV
1.5g
Q6
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes